Fluorine tagging of polyoxometalates: The cyclic [{Mov 2O4(H2O)}4{O3PC(CF 3)(O)PO3}4]12-

European Journal of Inorganic Chemistry

Volumn , Issue 25, 2010, Pages 3915-3919

  Banerjee, Abhishek ^a   Bassil, Bassem S ^a   Röschenthaler, Gerd Volker ^a   Kortz, Ulrich ^a  

^a JACOBS UNIVERSITY BREMEN   (Germany)

Author keywords

Diphosphonates; Fluorine; NMR spectroscopy; Polyoxometalates

Indexed keywords

NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDES; SINGLE CRYSTALS; X RAY DIFFRACTION;

AQUEOUS MEDIA; DIPHOSPHONATE; EFFICIENT STRATEGY; MULTINUCLEAR NMR SPECTROSCOPY; NMR-SPECTROSCOPY; POLYANIONS; POLYOXOMETALATES; SIMPLE++; THERMO-GRAVIMETRIC; X- RAY DIFFRACTIONS;

FLUORINE;

EID: 77956499416     PISSN: 14341948     EISSN: 10990682     Source Type: Journal    
DOI: 10.1002/ejic.201000468     Document Type: Article

References (50)

1. a) M. T. Pope, Heteropoly and Isopoly Oxometalates, Springer-Verlag, Berlin, 1983;
2. C. L. Hill, C. M. Prosser-McCartha, Coord. Chem. Rev. 1995, 143, 407-455;
3. M. T. Pope, A. Müller, Angew. Chem. Int. Ed. Engl. 1991, 30, 34-48;
4. Chem. Rev. 1998, 98 (Special Issue on Polyoxometalates; Ed.: C. L. Hill);
5. A. Müller, S. Roy, Coord. Chem. Rev. 2003, 245, 153-166;
6. E. Coronado, P. Day, Chem. Rev. 2004, 104, 5419-5448;
7. L. Cronin, in Compr. Coord. Chem. II, vol. 7 (Eds.: J. A. McCleverty, T. J. Meyer)
8. Elsevier, Amsterdam, 2004, pp. 1-57;
9. C. L. Hill, J. Mol. Catal. A 2007, 262, 2-6;
10. U. Kortz, A. Müller, J. van Slageren, J. Schnack, N. S. Dalal, M. Dressel, Coord. Chem. Rev. 2009, 253, 2315-2327;
11. Eur. J. Inorg. Chem. 2009, 34 (Issue dedicated to Polyoxometalates; Guest Ed.: U. Kortz).
12. a) U. Kortz, G. B. Jameson, M. T. Pope, J. Am. Chem. Soc. 1994, 116, 2659-2660;
13. U. Kortz, M. T. Pope, Inorg. Chem. 1994, 33, 5643-5646;
14. U. Kortz, M. T. Pope, Inorg. Chem. 1995, 34, 2160-2163;
15. U. Kortz, M. T. Pope, Inorg. Chem. 1995, 34, 3848-3850;
16. U. Kortz, Inorg. Chem. 2000, 39, 623-624;
17. U. Kortz, Inorg. Chem. 2000, 39, 625-626.
18. a) U. Kortz, F. Hussain, M. Reicke, Angew. Chem. Int. Ed. 2005, 44, 3773-3777;
19. S. S. Mal, U. Kortz, Angew. Chem. Int. Ed. 2005, 44, 3777-3780;
20. L.-H. Bi, M. H. Dickman, U. Kortz, I. Dix, Chem. Commun. 2005, 3962-3964;
21. B. S. Bassil, S. S. Mal, M. H. Dickman, U. Kortz, H. Oelrich, L. Walder, J. Am. Chem. Soc. 2008, 130, 6696-6697.
22. a) E. V. Chubarova, M. H. Dickman, B. Keita, L. Nadjo, F. Miserque, M. Mifsud, I. W. C. E. Arends, U. Kortz, Angew. Chem. Int. Ed. 2008, 47, 9542-9546;
23. N. V. Izarova, M. H. Dickman, R. Ngo Biboum, B. Keita, L. Nadjo, V. Ramachandran, N. S. Dalal, U. Kortz, Inorg. Chem. 2009, 48, 7504-7506;
24. N. V. Izarova, R. Ngo Biboum, B. Keita, M. Mifsud, I. W. C. E. Arends, G. B. Jameson, U. Kortz, Dalton Trans. 2009, 9385-9387;
25. N. V. Izarova, N. Vankova, T. Heine, R. Ngo Biboum, B. Keita, L. Nadjo, U. Kortz, Angew. Chem. Int. Ed. 2010, 49, 1886-1889.
26. a) R. Bartl, B. Frisch, E. Tresckow, C. Bartl, Bisphosphonates in Medical Practice, Springer-Verlag, Berlin, Heidelberg, 2007;
27. H. Fleisch, Bisphosphonates in Bone Diseases: From the Laboratory to the Patient, Academic Press, San Diego, California, USA, 2000;
28. H. Fleisch, Breast Cancer Res. 2002, 4, 30-34;
29. D. Wysowski, J. Chang, Arch. Intern. Med. 2005, 165, 346-347;
30. D. M. Black, P. D. Delmas, R. N. Eastell, Engl. J. Med. 2007, 356, 1809-1822;
31. S. R. Heckbert, G. Li, S. R. Cummings, N. L. Smith, B. M. Psaty, Arch. Intern. Med. 2008, 168, 826-831.
32. S. G. Sarafianos, U. Kortz, M. T. Pope, M. J. Modak, Biochem. J. 1996, 319, 619-626.
33. a) P. Peloux, A. Dolbecq, P. Mialane, J. Marrot, F. Sécheresse, Dalton Trans. 2004, 1259-1263;
34. A. Dolbecq, L. Lisnard, P. Mialane, J. Marrot, M. Benard, M. M. Rohmer, F. Sécheresse, Inorg. Chem. 2006, 45, 5898-5910.
35. E. Dumas, C. Sassoye, K. D. Smith, S. C. Sevov, Inorg. Chem. 2002, 41, 4029-4032.
36. a) G.-V. Röschenthaler, Nachr. Chem. 2005, 53, 743-746;
37. P. Kirsch, Modern Fluoroorganic Chemistry, Wiley-VCH Verlag, Weinheim, 2004;
38. K. Uneyama, Organofluorine Chemistry, Blackwell Publishing, UK, 2006;
39. I. Ojima, Fluorine in Medicinal Chemistry and Chemical Biology, Wiley-Blackwell, UK, 2009;
40. S. Poonam, W. D. Andrew, J. Enzym. Inhib. Med. Chem. 2007, 22, 527-540.
41. a) S. H. Wasfi, W. L. Johnson, Synth. React. Inorg. Met. Org. Chem. 1999, 29, 697-724;
42. S. H. Wasfi, W L. Johnson, D. L. Martin, Synth. React. Inorg. Met. Org. Chem. 1998, 28, 223-244;
43. S. H. Wasfi, W L. Johnson, D. L. Martin, Synth. React. Inorg. Met. Org. Chem. 1997, 27, 535-549;
44. S. H. Wasfi, C. E. Costello, A. L. Rheingold, B. S. Haggerty, Inorg. Chem. 1991, 30, 1788-1792;
45. A. K. Stover, J. R. Gutnick, A. N. Sarjeant, A. J. Norquist, Inorg. Chem. 2007, 46, 4389-4391;
46. A. Michailovski, F. Hussain, B. Spingler, J. Wagler, G. R. Patzke, Cryst. Growth Des. 2009, 9, 755-765.
47. J. D. Compain, A. Dolbecq, J. Marrot, P. Mialane, F. Sécheresse, Compt. Rend. Chim. 2010, 13, 329-335.
48. R. M. Schoth, E. Lork, F. U. Seifert, G.-V. Röschenthaler, Naturwissenschaften 1996, 83, 571-574.
49. M. Sekine, K. Okimoto, K. Yamada, T. Hata, J. Org. Chem. 1981, 46, 2097-2107.
50. GM. Sheldrick, SADABS, University of Göttingen, Göttingen, Germany, 1996.